COL1A1 and breast carcinoma: Its expression in breast cancer was found negatively correlated with the mRNA and protein expression of the DNA methyltransferase DNMT3A, which can alter global DNA methylation levels and, amongst others, result in increased collagen type I (COL1A1) promoter activity, contributing to high MD [36].